UTHR

#467
United Therapeutics Corp
503.90
+0.81%
Sector:
Base:
Profit Currency:
Daily Range
503.90
503.90
Year Range
266.98
537.11
Daily Change
+0.81%
Monthly Change
+6.24%
6 month change
+64.90%
Year Change
+55.52%
Previous Close
499.83
Open
503.90
Bid
Ask
Low
503.90
High
503.90
Volume
184
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 22.32 B
  • Employee 1 305
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
17.49
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

News